77 completed, 23 unknown, 5 recruiting, 5 terminated. 117 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 117 | Completed 77, Unknown 23, Recruiting 5, Terminated 5, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1 |
Follow Motor Activity: new trials by email Literature Review of Motor Activity trials Research Report on Motor Activity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The INTERvening for LUNG Health Trial Community health worker-delivered multi-component respiratory health intervention - Spirometry | Phase 4 | Not yet recruiting | Johns Hopkins University | 800 | 2026-11-15 | 2026-10-08 |
| FutureShape Family Family Care, Standard Care, Semaglutide (administered by PDS290 pen-injector) - Obesity, Overweight | Phase 4 | Recruiting | Signe Torekov | 400 | 2026-10-01 | 2026-10-29 |
| Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes semaglutide, Moderate-Intensity Resistance Exercise, Balance and Tone (BAT) Exercise - Type 2 Diabetes, Cognitive Decline in Older Adults | Phase 4 | Not yet recruiting | Western University, Canada | 164 | 2026-09-01 | 2026-08-20 |
| A Study to See if an Energy Drink With Caffeine and Green Tea Increases Fat Burning When Exercising Active (Green tea and caffeine), Placebo - Exercise | Phase 4 | Active not recruiting | RDC Clinical Pty Ltd | 36 | 2026-03-26 | 2026-10-27 |
| Exercise and Olanzapine-samidorphan Olanzapine-samidorphan + exercise - Schizophenia Disorder, Schizoaffective Disorder | Phase 4 | Recruiting | New York State Psychiatric Institute | 30 | 2025-06-26 | 2026-07-13 |
| 12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence Cytisinicline and exercise, Cytisinicline - Smoking Cessation | Phase 4 | Unknown | Maimónides Biomedical Research Institute of Córdoba | 150 | 2025-01-01 | 2024-09-04 |
| Bronchodilators and Lung Mechanics During Exercise in COPD Bronchodilators inhalation, Placebo - COPD | Phase 4 | Recruiting | Dr. J. Alberto Neder | 25 | 2024-11-10 | 2025-02-13 |
| Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia exercise, whey protein powder, Eldecalcitol - Sarcopenia | Phase 4 | Recruiting | Zhejiang Provincial People's Hospital | 450 | 2024-06-16 | 2024-08-05 |
| Amino Acids Supplementation and Exercise Intervention in Hemodialysis Patients ketoanalogue supplementation, intradialytic exercise - Hemodialysis Complication, Malnutrition | Phase 4 | Unknown | Mansoura University | 100 | 2024-05-12 | 2024-09-19 |
| LIROH - Liraglutide for Obesity in HIV Liraglutide - Obesity, HIV Infections | Phase 4 | Unknown | Brigham and Women's Hospital | 40 | 2024-05-02 | 2024-05-31 |
| Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure IV Iron Infusion Group - Heart Failure, Iron-deficiency | Phase 4 | Terminated | Radha Gopalan | 6 | 2024-01-24 | 2026-07-29 |
| Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance Acetazolamide 250Mg Tab, Methazolamide Pill, Placebo - High Altitude Effects | Phase 4 | Completed | University of Waterloo | 15 | 2023-08-11 | 2024-03-12 |
| Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes Control, Albuterol - Asthma in Children, Dyspnea; Asthmatic | Phase 4 | Withdrawn | Ohio State University | 2023-07-01 | 2023-11-07 | |
| Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects Behavioral Treatment, Placebo, Semaglutide 2.4 MG/0.75 ML Subcutaneous Solution [WEGOVY] - Obesity | Phase 4 | Completed | University of Pennsylvania | 120 | 2022-07-26 | 2026-08-03 |
| The Influence of Capsaicin Gel During Exercise Within the Heat Capsaicin, Control Gel, Exercise - Acute Exercise, Heat Exposure | Phase 4 | Completed | University of Nebraska | 12 | 2022-05-25 | 2024-03-15 |
| The Influence of Menthol Gel During Exercise With Heat Menthol Gel, Control Gel - Acute Exercise, Heat Exposure | Phase 4 | Completed | University of Nebraska | 12 | 2022-05-01 | 2024-04-24 |
| Water-based Activity to Enhance Recall in Veterans: A Randomized Clinical Trial Usual Care, WATER+CT - Mild Cognitive Impairment | Phase 4 | Completed | VA Office of Research and Development | 121 | 2022-01-03 | 2026-09-14 |
| Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction Empagliflozin 10 MG - Heart Failure with Preserved Ejection Fraction, Heart Failure, Diastolic | Phase 4 | Completed | University of Texas Southwestern Medical Center | 8 | 2021-11-09 | 2024-09-19 |
| Effect of Coconut Water on Hydration Status in Pediatric Population Coconut Water, Oral Electrolytes - Sports Nutrition | Phase 4 | Completed | Universidad de Colima | 34 | 2021-10-15 | 2025-02-21 |
| The Effects of a Single Dose of Methylphenidate on Motor Performance MPH - ADHD | Phase 4 | Unknown | Loewenstein Hospital | 200 | 2021-05-27 | 2023-12-20 |
Showing 20 of 117. Sign in to see all of them.
Pulmonary Disease, Chronic Obstructive (19) · Diabetes Mellitus, Type 2 (8) · Obesity (8) · Cardiovascular Diseases (7) · Diabetes Mellitus (7) · Heart Failure (7) · Dyspnea (6) · Asthma (5) · Overweight (5) · Hypertension (4) · Insulin Resistance (4) · Depression (3) · Diabetes Mellitus, Type 1 (3) · Osteoarthritis, Knee (3)
Behavior (115) · Pathological Conditions, Signs and Symptoms (47) · Nutritional and Metabolic Diseases (35) · Respiratory Tract Diseases (28) · Lung Diseases (26) · Pathologic Processes (26) · Signs and Symptoms (26) · Metabolic Diseases (25) · Lung Diseases, Obstructive (23) · Chronic Disease (22) · Disease Attributes (22) · Endocrine System Diseases (18) · Glucose Metabolism Disorders (18) · Immune System Diseases (16) · Cardiovascular Diseases (15)
Exercise (24) · Metformin (6) · Tiotropium Bromide (4) · Acetazolamide (3) · Albuterol (3) · Atenolol (3) · Budesonide (3) · Formoterol Fumarate (3) · Insulin Glargine (3) · Resistance Training (3) · Standard of Care (3) · semaglutide (3) · Carvedilol (2) · Cholecalciferol (2) · Fluticasone-Salmeterol Drug Combination (2)
Novartis Pharmaceuticals (4) · GlaxoSmithKline (3) · Laval University (3) · Queen's University (3) · Taipei Medical University (3) · Amsterdam UMC, location VUmc (2) · Brigham and Women's Hospital (2) · Centro Cardiologico Monzino (2) · LMC Diabetes & Endocrinology Ltd. (2) · Pennington Biomedical Research Center (2) · Population Health Research Institute (2) · University of Copenhagen (2) · University of Nebraska (2) · Actelion (1) · Arizona State University (1)
United States (33) · Canada (17) · Brazil (9) · Denmark (7) · Italy (7) · Germany (6) · Australia (4) · Netherlands (4) · Spain (4) · Taiwan (4) · Argentina (2) · China (2) · France (2) · Israel (2) · Portugal (2)
Denis E O'Donnell, MD (3) · Bronwyn A Kingwell, PhD (2) · David A Dzewaltowski, Ph.D. (2) · Flemming Dela, MD, MDSci (2) · Piergiuseppe Agostoni, MD, PhD (2) · Ru-Lan Hsieh, MD (2) · Stefano Palomba, MD (2) · Abby Shevitz, MD (1) · Aline AF Fofonka, MSc (1) · Anton Vonk-Noordegraaf, Prof MD PhD (1) · Barbara E. Ainsworth, Ph.D. (1)
PMID 11580731, PMID 17046300, PMID 18317385, PMID 19000239, PMID 19187083, PMID 19300114, PMID 19447919, PMID 19470987, PMID 19711095, PMID 19858314, PMID 19943971, PMID 20040610, PMID 20046616, PMID 20539245, PMID 20858697, PMID 21144055, PMID 21205384, PMID 21450573, PMID 21459735, PMID 21494337, PMID 21864137, PMID 21864865, PMID 21918235, PMID 22338607, PMID 22530610, PMID 22894138, PMID 22947543, PMID 23385271, PMID 23558890, PMID 23730808, PMID 24089589, PMID 24153001, PMID 24397981, PMID 24589566, PMID 24651512, PMID 24928953, PMID 24952265, PMID 24976447, PMID 25118076, PMID 25366037, PMID 25372005, PMID 26067552, PMID 26401247, PMID 26658988, PMID 27326819, PMID 27433488, PMID 28324049, PMID 28479217, PMID 29479457, PMID 29615792
2009 (1), 2017 (1), I01RX003143 (1), K23DK125162 (1), R01AR071263 (1), R01ES037151 (1), R01HD037367 (1), R01MH071268 (1)